Literature DB >> 10758055

Genetic manipulation of the rabbit heart via transgenesis.

J James1, A Sanbe, K Yager, L Martin, R Klevitsky, J Robbins.   

Abstract

BACKGROUND: Transgenesis using cardiac-specific expression has been valuable in exploring cardiac structure-function relationships. To date, cardiac-selective studies have been confined to the mouse. However, the utility of the mouse is limited in certain, possibly critical, aspects with respect to cardiovascular function. METHODS AND
RESULTS: To establish the potential validity of transgenic methodology for remodeling a larger mammalian heart, we explored cardiac-selective expression in transgenic rabbits. The murine alpha- and beta-cardiac myosin heavy chain gene promoters were used to express a reporter gene, and transgene expression was quantified in cardiac, skeletal, and smooth muscles as well as in nonmuscle tissues. Although neither promoter exactly mimics endogenous patterns of myosin heavy chain expression, both are able to drive high levels of transgene expression in the cardiac compartment. Neither promoter is active in smooth muscle or nonmuscle tissues.
CONCLUSIONS: Directed organ-specific expression is feasible in a larger animal with existing reagents, and cardiac-selective transgenic manipulation is possible in the rabbit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758055     DOI: 10.1161/01.cir.101.14.1715

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions.

Authors:  Jeanne James; Lisa Martin; Maike Krenz; Carmen Quatman; Fred Jones; Raisa Klevitsky; James Gulick; Jeffrey Robbins
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

2.  Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.

Authors:  Atsushi Sanbe; Jeanne James; Volkan Tuzcu; Selman Nas; Lisa Martin; James Gulick; Hanna Osinska; Sadayappan Sakthivel; Raisa Klevitsky; Kenneth S Ginsburg; Donald M Bers; Bruce Zinman; Edward G Lakatta; Jeffrey Robbins
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

3.  Phospholamban overexpression in transgenic rabbits.

Authors:  James Scott Pattison; Jason R Waggoner; Jeanne James; Lisa Martin; James Gulick; Hanna Osinska; Raisa Klevitsky; Evangelia G Kranias; Jeffrey Robbins
Journal:  Transgenic Res       Date:  2007-09-19       Impact factor: 2.788

4.  Effects of myosin heavy chain manipulation in experimental heart failure.

Authors:  Jeanne James; Kan Hor; Michael-Alice Moga; Lisa Ann Martin; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2009-10-22       Impact factor: 5.000

Review 5.  The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.

Authors:  Zs Bosze; L Hiripi; J W Carnwath; H Niemann
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

6.  Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome.

Authors:  Michael Brunner; Xuwen Peng; Gong Xin Liu; Xiao-Qin Ren; Ohad Ziv; Bum-Rak Choi; Rajesh Mathur; Mohammed Hajjiri; Katja E Odening; Eric Steinberg; Eduardo J Folco; Ekatherini Pringa; Jason Centracchio; Roland R Macharzina; Tammy Donahay; Lorraine Schofield; Naveed Rana; Malcolm Kirk; Gary F Mitchell; Athena Poppas; Manfred Zehender; Gideon Koren
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Effects of cardiac myosin isoform variation on myofilament function and crossbridge kinetics in transgenic rabbits.

Authors:  Takeki Suzuki; Bradley M Palmer; Jeanne James; Yuan Wang; Zengyi Chen; Peter VanBuren; David W Maughan; Jeffrey Robbins; Martin M LeWinter
Journal:  Circ Heart Fail       Date:  2009-03-30       Impact factor: 8.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.